Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Withdraws Two Temporary COVID FSMA Guidances

The U.S. Food and Drug Administration is withdrawing the following two temporary guidances, originally published during the COVID-19 public health emergency, regarding human and animal foods that involve onsite visits under the FDA Food Safety Modernization Act: 

  • Temporary Policy Regarding Preventive Controls and FSVP Food Supplier Verification Onsite Audit Requirements Due to COVID-19 
  • Temporary Policy Regarding Accredited Third-Party Certification Program Onsite Observation and Certificate Duration Requirements Due to COVID-19 

In these two documents, the agency issued guidance on onsite auditing and observations requirements, to assist firms responding to the COVID-19 pandemic and help ensure continued food safety and availability during the pandemic.  

As COVID no longer causes travel to be impracticable to any significant extent, these temporary guidances are no longer relevant or needed and are being withdrawn.  To ensure that industry is not surprised by the change in policy, the withdrawals will be effective in 90 days, or on 16 June, 2026.  

Background 

When the U.S. COVID-19 public health emergency declaration officially ended in May 2023, the FDA recognized certain firms might still be impacted by COVID-19 travel restrictions and advisories.  Accordingly, in July 2023 the FDA reissued two temporary COVID-era FSMA guidances for certain regulatory requirements involving onsite activities. 

When certain circumstances were present, including but not limited to, when COVID-19 travel restrictions prevented onsite visits, the temporary guidances addressed supplier onsite activities for the FSMA Preventive Controls for Human and Animal Food rules and the Foreign Supplier Verification Programs rule, and onsite monitoring activities and duration of already-issued certifications for the Accredited Third-Party Certification Program. 

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.